ZOLEDRONAT Accord onco 4 mg/5 ml conc perf 1 pce

7680670710015 CH-67071 M05BA08 07.99.0.

Active substances:

ZOLEDRONAT Accord onco 4 mg/5 ml conc perf 1 pce
ZOLEDRONAT Accord onco 4 mg/5 ml conc perf 1 pce
ZOLEDRONAT Accord onco 4 mg/5 ml conc perf 1 pce
1 / 3
google

Details

Product number
6707101
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
acidum zoledronicum 4 mg ut acidum zoledronicum monohydricum, mannitolum, natrii citras anhydricus corresp. natrium 6.41 mg, aqua ad iniectabile q.s. ad solutionem pro 5 ml.

Articles (1)

Zoledronat Accord onco 4 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
09/06/2026
Professional SmPC
Français
09/06/2026
Professional SmPC
Italien
09/06/2026

Detailed composition

Substance Quantity Type Category
acidum zoledronicum
4.0 MG Substance Wirkstoff (Principe actif)
acidum zoledronicum monohydricum
- Substance WIZUS
mannitolum
- Substance HNIDK
natrii citras anhydricus
- Substance HNIDK
natrium
6.41 MG Substance HBESI
aqua ad iniectabile
- Substance HNIDK

Authorization holder

Accord Healthcare AG

4103 Bottmingen

Authorization information

Swissmedic authorization number
67071
Drug name
Zoledronat Accord onco 4 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
M05BA08
Authorization status
Z
Dispensation category
B
First authorization
23/05/2019
Authorization expiration date
31/12/9999
IT number
07.99.0.
Domain
Human medicine
Field of application
Knochenmetastasen solider Tumore und multiples Myelom, maligne Hyperkalzämie

Packaging details

Description (FR)
ZOLEDRONAT Accord onco 4 mg/5 ml conc perf 1 pce
Description (DE)
ZOLEDRONAT Accord onco 4 mg/5 ml Konz Inf 1 Stk
Market launch
23/05/2019
Narcotic (BTM)
No

Available generics

Zoledronat Fresenius Onco, Konzentrat zur Herstellung einer Infusionslösung
CHF 124.00
View
Zoledronat Onco Labatec, 4 mg/100 ml, solution pour perfusion
CHF 134.10
View
Zoledronat Onco Labatec 4 mg/5 ml, solution à diluer pour perfusion
CHF 134.10
View
Zoledronat OSTEO Labatec, solution pour perfusion
CHF 220.65
View
Zoledronat Osteo Sandoz 5 mg/100 ml, Infusionslösung
CHF 220.65
View
Zoledronat Osteo Spirig HC, Infusionslösung
CHF 220.65
View
Zoledronat-Teva onco, Konzentrat zur Herstellung einer Infusionslösung
CHF 134.10
View
Zoledronsäure Onco Sandoz 4 mg / 100 ml, Infusionslösung
CHF 134.10
View
Zoledronsäure Onco Sandoz 4 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung
CHF 134.10
View
Buy us a coffee Explore the data